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Essentials
• Activation-dependent platelet surface expression of different receptors was analyzed.
• Changes in surface expression depended on both the receptor and the platelet agonist.
• Newly expressed receptors localize on lamellipodia of platelets spread on fibrinogen.
• Increased receptor expressions upon activation are mainly manifested in larger platelets.
| INTRODUCTION
Platelets are anucleate small blood cells, but they have several intracellular organelles and membrane systems whose localization and morphology are changed upon platelet activation by various stimulants. Activation transforms the smooth disclike shape of resting platelets to a disturbed spherical shape with numerous filopodial extrusions and lamellipodia, accompanied by marked changes in subcellular organelle localization. Secretory dense granules and α-granules extrude their contents to the extracellular medium or through the inside space of the open canalicular system (OCS), and granule membranes fuse with the plasma or OCS membrane. [1] [2] [3] [4] Major receptor proteins contained in the OCS and α-granule membranes, including glycoprotein (GP) Ib and αIIbβ3, 1,2 become exposed to the surface when their membranes fuse with the platelet plasma membrane. This may explain increased surface αIIbβ3 expression in activated platelets, 1,2 but a decrease in surface GPIb 5, 6 upon activation suggests that other mechanisms may be involved.
Platelets are essential for primary hemostasis since they adhere to subendothelial collagen exposed by vessel injury, become activated, aggregate, and form a thrombus to arrest bleeding.
Hyperactive platelets, however, lead to formation of unwanted thrombi, which can detach and travel to distal areas, causing ischemic stroke or cardiovascular disease (CVD). Larger platelet size, measured as increased mean platelet volume (MPV), is a risk factor for cardiovascular disease CVD. 7, 8 MPV increases with age in mice, which might explain the increasing CVD risk in the elderly. 9 Circumstantial evidence suggests that large platelets are more active, but there is yet no direct evidence for this and why this may be so.
The aim of the present study is to compare larger platelets with the whole platelet population in terms of their surface expressions of receptors involved in thrombus formation in response to platelet activation using a clinically available method, flow cytometry.
In resting platelets, surface expressions of GPIb, αIIbβ3, α2β1, and GPVI were higher in the larger platelets, commensurate with their larger surface area. Expressions of αIIbβ3 and α2β1 were increased in activated platelets, but GPIb and GPVI decreased due to shedding, internalization, or both. Increased exposure of intracellular receptors upon activation was most prominent in the larger platelets.
These results suggest that platelets are a heterogeneous population, not only with respect to size but importantly with respect to activity and that the large platelets are the main determinants of platelet activation and function. and crosslinked collagen-related peptide (CRP-XL) 13 were previously reported.
| MATERIALS AND METHODS

| Materials
| Flow cytometry to measure surface receptor expression
Platelet-rich plasma (PRP), prepared from acid-citrate-dextrose-anticoagulated blood from healthy volunteers, 10 was diluted 4-fold with modified HEPES (4-[2-hydroxyethyl]-1piperazineethanesulfonic acid)-Tyrode's buffer (HT: 136 mmol/L NaCl, 2.7 mmol/L KCl, 0.42 mmol/L NaH 2 PO 4 , 5.5 mmol/L glucose, 5 mmol/L HEPES, pH 7.4) or washed platelets (5 × 10 7 cells/ mL, HT) were prepared as before. 10 Platelets were activated by CRP-XL (5 μg/mL), Cvx (0.5 μg/mL), or thrombin (0.2 U/mL) for 4 minutes at 37°C. Samples were prepared for flow cytometry (Accuri C6, BD Biosciences, San Jose, CA, USA), 10 with receptorspecific primary antibody and Alexa Fluor-488-conjugated antimouse Fab (50 μg/mL; Jackson Immuno-Research Laboratories, West Grove, PA, USA) as secondary antibody. The negative control was isotype control IgG or control mouse Fab. Platelet receptor expression was expressed as median fluorescence intensity (MFI) obtained for binding of receptor-specific antibody.
In each experiment, the whole platelet population (P1) of a donor's platelets was divided into 2 subpopulations according to size by gating in the forward scatter/side scatter (FSC/SSC) plot: The larger half was defined as P2 (larger platelets) and the smaller half was defined as P3 (smaller platelets; Figure 1A shows an example).
Numbers of platelets in each subpopulation are calculated as percentage of total events.
| Analysis of receptor expression in fixed platelets
Washed platelets (200 μL, 5 × 10 8 cells/mL,) were activated (CRP-XL or thrombin) for 4 minutes and mixed with 200 μL cold 8% formaldehyde/0.4% glutaraldehyde/PBS; after 30 minutes on ice, the mixture was diluted with 4 mL cold citrate-buffered saline (CBS: 6.85 mmol/L citrate, 130 mmol/L NaCl, 4 mmol/L KCl, 5.5 mmol/L glucose buffer, pH 6.5) containing 5 mmol/L ethylenediaminetetraacetic acid (EDTA) and centrifuged in a microfuge (1000 g, 10 minutes). Each pellet was resuspended in 100 μL HT, and antibody binding was determined by flow cytometry.
Formaldehyde/glutaraldehyde solution was used, as it has less effect on cell membrane phospholipid distribution 14 and better maintained platelet antibody binding.
| Immunoblotting
Washed platelets (200 μL, 10 9 cells/mL) were activated with CRP-XL (5 μg/mL), Cvx (0.5 μg/mL), or thrombin (0.5 U/mL) for 5 minutes at 37°C followed by 30 minutes at room temperature. Suspensions were centrifuged to separate supernatants and platelet pellets, which were dissolved with 200 μL 6 mol/L urea/1% SDS. Non-reducing F I G U R E 1 Flow cytometric analysis of large platelets. A, Resting and crosslinked collagen-related peptide (CRP-XL; 5 μg/mL)-activated platelets in platelet-rich plasma (PRP) were analyzed by flow cytometry. Both the resting and CRP-XL-activated platelets were gated into 2 populations from their FSC/SSC plots (left plots): P1 (the total platelet population) and the larger half of P1 (P2). Since the Acuri C6 flow cytometer cannot delineate the larger half of the population from the lower half, we manually drew the gating line for each preparation analyzed. The fluorescence of P1 and that of P2, expressed as median fluorescence intensity (MFI), are shown in the middle and right plots for the resting and CRP-activated platelets. B, Each P2/P1 ratio (reported as %) is calculated from the MFI of P1 and the MFI of P2. This figure summarizes from results for PRP and washed platelets, with different activators and specific antibodies (shown in parentheses) to determine expressions of total GPVI (1G5), GPVI-dimer (204-11 Fab), integrin α2β1 (Gi9), integrin αIIbβ3 (M148), and GPIb (AK2). Each bar in the graphs and their associated error bar show the mean ± standard deviation of the indicated number of determinations. P1/P2 for each receptor of platelets activated with CRP-XL, convulxin (Cvx), or thrombin was compared to the respective P1/P2 of resting platelets. For PRP, CRP-XL increased the ratio of GPVI-dimer (P = .000, n = 5) and ratios of α2β1 (P = .08, n = 4) and αIIbβ3 (P = .08, n = 5) tended to be higher. Cvx also increased the ratio of GPVI-dimer (P = .007, n = 6), α2β1 (P = .03, n = 4), GPIb (P = .02, n = 4), and αIIbβ3 (P = .02, n = 5). However, thrombin only increased the ratio of GPVI-dimer (P = .03, n = 4). For washed platelets, the P2/P1 ratios are increased compared to those of the corresponding resting platelets after the activation by CRP-XL (GPVI dimer: P = .01, n = 8; α2β1: P = .003, n = 5; GPIb: P = .11, n = 7; αIIbβ3: P = .002, n = 7); Cvx (GPVI dimer: P = .05, n = 7; α2β1: P = .002, n = 5; GPIb: P = .00, n = 7; αIIbβ3: P = .00, n = 6); and thrombin (GPVI-dimer: P=<0.00, n = 13; α2β1: P = .02, n = 5; GPIb: P = .005, n = 7; αIIbβ3: P < .0001, n = 11). *P ≤ .05, **P ≤ .005, ***P ≤ .0005, ****P < . 10 3.4 10 4 10 5 10 6 10 6.5 10 1 10 2 10 3 10 4 10 5 10 6 10 7.2 10 1 10 2 10 3 10 4 10 5 10 6 10 7.2 10 3.4 10 4 10 5 10 6 10 6.5 10 1 10 2 10 3 10 4 10 5 10 6 10 7.2 10 1 10 2 10 3 10 4 10 5 10 6 10 7. Laemmli's SDS sample buffer was added to each sample and heated 
| Confocal imaging of internalization and surface receptor expression
| GPIb and GPVI internalization
| Receptors newly exposed upon platelet activation
Washed platelets prelabeled with Alexa Fluor-488-labeled clone 486805 mAb, 204-11 Fab or M148 were allowed to adhere to Hormcollagen-or fibrinogen-coated MatTek dishes (60 minutes, 37°C).
Dishes were washed with PBS, and adhered platelets were fixed with 10% formaldehyde and blocked with 1% BSA/PBS. The platelets prelabeled with 204-11 Fab, clone 48605 Mab, and M148 were reacted with Alexa Fluor-647-labeled 1G5, 486805 Mab, and M148, respectively; washed; and imaged.
| Verification of GPVI internalization
1G5 was labeled with sulfo-NHS-SS-biotin (Thermo Fisher Scientific, Waltham, MA, USA) to form the biotinylated antibody (1G5-SS-biotin).
Washed platelets were incubated with 1G5-SS-biotin and Alexa Fluor 647-streptavidin. Then excess biotin was added; 10 minutes later, the mixture was diluted with CBS and centrifuged to obtain the platelet pellet. The pellet was resuspended in HT, and aliquots were activated with Cvx (1 μg/mL) or thrombin (0.2 units/mL), followed by addition of TCEP (tris[2-carboxyethyl]phosphine; 28 mmol/L, final; Thermo Fisher Scientific, Waltham, MA, USA). Samples were processed for confocal microscopy to visualize the remaining GPVI-associated fluorescence.
| Statistical analysis
Paired Student's t-test (Prism v8.9, GraphPad Software, La Jolla, CA, USA) was applied to compare differences between activated platelets and their corresponding resting platelets.
| RESULTS
| Large platelets have higher levels of surface receptor expression
From the SSC/FSC scatter plot, resting platelets of each donor were gated into the larger platelets (P2) of the total population (P1; Figure 1A , resting platelets). Because each donor's platelets showed a different size distribution, gating was tailored to each donor's FSC/ SSC plot. P2 of resting platelets showed 1.5-fold higher binding of anti-GPVI dimer (204-11 Fab) than P1. CRP-XL activation slightly changed the scatter plot ( Figure 1A , activated) and P2, defined by the same gating as used for resting platelets, exhibited 1.9-fold higher 204-11 binding than P1.
Thus, we determined if the P2 population also showed higher numbers of other platelet surface receptors, using specific primary antibodies: total GPVI (1G5), GPIb (AK2), αIIbβ3 (M148), and α2β1 (Gi9), using isotype IgG (control) to determine background fluorescence (black bar [control] in Figure 1B ) under each condition (resting, CRP, Cvx, thrombin).
P2/P1 of control resting platelets was about 130%, showing that P2 bound more control IgG than P1, indicating that P2
platelets have a larger cell surface area. For all receptors, except for total GPVI, P2/P1 ratios were similar to that of the control.
The higher P2/P1 for total GPVI ( Figure 1B : PRP, P < .0001, n = 7;
washed platelets, P < .0004, n = 5) is due to the ability of 1G5 to activate platelets. 11
For PRP added with agonist, only some of the P2/P1 data were significantly higher than the respective resting control: for CRP: dGPVI (P < .0001, n = 5); for Cvx: dGPVI (P < .007, n = 5), α2β1 (P < .028, n = 4), GPIb (P < .020, n = 4), αIIbβ3 (P < .019, n = 5); for thrombin: dGPVI (P < .025, n = 4). Although the P2/P1 for each receptor was higher than the ratio in the resting plate- 
| Receptor expression after platelet activation
Surface receptor expressions in platelets activated by CRP-XL, Cvx, and thrombin were determined and compared to expression of each receptor in resting platelets ( Figure 2 ). For the total platelet population (P1) of PRP (Figure 2A ), both total GPVI and GPVI dimer very markedly decreased after stimulation by Cvx (GPVI dimer: P = .03, n = 5; total GPVI: P = .000, n = 4), but no significant changes in expression of either in response to CRP-XL or thrombin.
α2β1 and αIIbβ3 expressions tended to increase after activation but P1 of washed platelets ( Figure 2C) showed changes similar to those for P1 of PRP, but they became more significant because of the larger number of measurements. GPVI expression is strongly decreased by Cvx (GPVI dimer: P < .0001, n = 7; total GPVI: P < .0001, n = 6). GPVI dimer, but not total GPVI, is slightly increased by thrombin (P = .0158, n = 13). None of the agonists changed α2β1 expression. αIIbβ3 expression tended to increase after activation (CRP-XL: P = .03, n = 7; Cvx: P = .08, n = 6; thrombin: P = .003, n = 11). Surface GPIb expression, however, strongly decreased in response to each agonist: CRP-XL (P = .02, n = 7), Cvx (P < .0001, n = 7), and thrombin (P < .0001, n = 7).
If we compare the differences in receptor expression in the P2 population of PRP and washed platelets ( Figure 2B,D) , which has higher expression of each receptor than the total population (P1), the changes in surface receptor expression upon activation are even more dramatic.
To confirm these results, we determined receptor expression in stimulated washed platelets that were subsequently fixed with formaldehyde/glutaraldehyde; 204-11 Fab was not used in these experiments, as it does not react with fixed platelets. These activated and fixed platelets showed similar receptor changes; Cvx, especially, strongly reduced GPVI expression ( Figure 3A ).
| Time course and agonist-concentration dependency of receptor expression in activated platelets
Flow cytometry of activated platelets ( Figure 3B ) showed that total Thrombin-induced changes in expressions of GPVI dimer, P-selectin, and activated αIIbβ3 in P1-P3 were measured using 204-11 Fab, anti-CD62P, and PAC-1 antibodies, respectively.
All 3 receptors increased dose dependently with thrombin, but increases in P2 were much greater than those in P1 and P3
( Figure 4A ). Increase of GPVI dimer expression in P3 platelets was much less, and expressions of CD62P and active αIIbβ3 in P2
were more than 2-fold those in P3. Since anti-CD62P and PAC-1 bind only to activated platelets, these results indicate that the F I G U R E 3 Analyses of receptor expressions using fixed platelets. A, Receptor expressions in fixed platelets. After platelets were activated, as described in Figure 2 , they were fixed, stained using specific antibodies for the indicated receptors, and receptor expressions determined by flow cytometry. The increase or decrease of specific receptors in fixed platelets were similar to those obtained with native platelets. GPVI expression is decreased by convulxin (Cvx; P = .003, n = 8), but increased by crosslinked collagen-related peptide (CRP-XL) and thrombin (P = .003 and P = .003, respectively, n = 8). Integrin α2β1 tended to increase, although not reaching statistical significance, in platelets activated However, the percentage of total events increased slightly in P3 and decreased slightly in P2, suggesting that the platelets originally distributed in P2 would have increased their surface receptor expression. The slight decrease in the percentage of total events in P2 would be due to formation of aggregates.
| Analysis of GPIb and GPVI shedding
Platelet activation by CRP-XL, Cvx, or thrombin decreased surface GPIb 
| Internalization of GPIb and GPVI in activated platelets
Platelets, prelabeled with Alexa Fluor-488-conjugated antibodies against GPIb or GPVI, were activated by Cvx or thrombin, fixed, and 
| Exposure of intracellular receptors on platelet spreading
Our flow cytometry data suggest that additional receptors are newly exposed on the platelet surface after platelet activation. Preexisting surface receptors were differentiated from newly exposed ones by allowing platelets labeled with Alexa Fluor-488-conjugated receptor-specific antibody to adhere and spread on immobilized collagen or fibrinogen and then post-staining with the same antibody conjugated with Alexa Fluor-647. For GPVI dimers, platelets were prestained with Alexa Fluor-488 204-11 Fab and post-stained with
AlexaFluor-647-1G5, since 204-11 does not react with fixed platelets. Anti-GPVI dimer prelabeled platelets spread well on immobilized fibrinogen; prelabeled GPVI is localized on the cell body, but post-stained GPVI appears in the membrane, at the edges of the lamellipodia, of spread cells ( Figure 8A) . The GPIb-prestained cells are less spread but show differential staining similar to GPVI.
Platelets adhered to collagen ( Figure 8B ) have GPVI clusters along the collagen fibers, as previously reported, 15 with prestained and post-stained GPVI colocalized. This suggests that both preexisting and newly exposed GPVI moved to collagen's platelet-binding sites. Prestained GPIb is concentrated on the cell body, whereas post-stained GPIb is diffuse and mostly localized to the lamellipodia of the spread platelet; this is different from the platelets adhered to fibrinogen, as collagen strongly activated the platelets. However, prestained and post-stained αIIbβ3 are mainly colocalized, but strong prestaining is observed in the cell body. These results show that when platelets spread and a receptor does not interact with substrate, preexisting surface receptors reside at the cell body, while newly exposed receptors present at the edges of the lamellipodia in the spread platelet. If receptors react with substrate, preexisting and newly exposed receptors move to the binding site. Such conditions are typically present for GPVI on platelets adhering on fibrinogen and collagen.
| DISCUSSION
This study demonstrates that platelet activation changes the levels GPIb and GPVI are susceptible to cleavage by metalloproteinases ADAM17 and ADAM10, respectively, after platelet activation, so their soluble forms, glycocalicin and 55-KD GPVI, respectively, may be released into the medium. 16, 17 Under the conditions of our flow cytometry assays, GPIb, as glycocalicin, was detectable in the supernatant, although most of it remained on the platelets ( Figure 5 Increased receptor expression after activation could be explained by the merging of OCS and granule membranes with the surface membrane, which translocate intracellular receptors to the platelet surface. [1] [2] [3] [4] 18, 19 Thus, we can reasonably hypothesize that GPIb and GPVI expressions would first increase upon platelet activation and then decrease due to internalization, shedding, or both. Thrombin-induced increase in surface GPVI and its Cvx-induced decrease occur on similar time scales ( Figure 3B ), so GPVI internalization by Cvx must be rapid if intracellular GPVI is first cell-surface-expressed and then internalized. The observed differential expressions of surface GPVI induced by thrombin and Cvx raises several possibilities about the internalization process: GPVI expression may be increased by thrombin activation through a mechanism similar to that for the increase in αIIbβ3, while direct binding of Cvx to GPVI may induce GPVI internalization. Our results suggest that large-cluster formation may be required to induce strong internalization since CRP-XL produces little internalization. Cvx is a tetramer of heterodimers, 23 and while CRP-XL is a crosslinked molecule, it is composed of single triple-helical peptides, which do not bind to GPVI. 10 Thus, only Cvx would form dense GPVI clusters large enough to induce internalization.
In contrast to GPVI, many agonists have been reported to decrease GPIb expression, 21, 24 suggesting platelet activation in general would cause GPIb internalization. Electron micrographs suggested cytoskeletal involvement in GPIb internalization. [19] [20] [21] However, αIIbβ3 binds to the cytoskeleton as well and is clustered after activation but does not internalize, so the precise mechanism of internalization remains inconclusive.
Using prestaining and post-staining with receptor-specific antibodies labeled with fluorophores that emit fluorescence of different wavelengths, we differentiated preexisting surface receptors in resting platelets from intracellular receptors newly exposed upon platelet activation. Prestained GPVI on fibrinogen-adhered platelets localizes to the cell body in the center of the spread cell, while post-stained GPVI localizes at the edges of the spread cell ( Figure 8A ). However, platelets adhered on collagen show colocalization of prestained and post-stained GPVI clustered along the collagen fibers, as previously reported. 15 These results indicate that the flat, spread membrane of fibrinogen-adhered platelets would come from an intracellular resource, with newly exposed GPVI dispersed freely over the lamellipodia, but originally existing surface GPVI would remain at the same place. However, because of GPVI's high affinity for collagen, prestained (green) and post-stained GPVI (red) would move to the region of the membrane in contact with collagen fibers and become colocalized as membrane clusters on the fibers (yellow; Figure 8B ). Distribution of prestained and post-stained GPIb on platelets adhered to immobilized fibrinogen and collagen are essentially like that of GPVI on platelets adhered on fibrinogen, but since these platelets are not fully spread like the GPVI-stained platelets, many of the spread cells show only a small separation of post-and prestaining. These results suggest that intracellular receptors become exposed in the spread membrane (lamellipodia) of adhered platelets and localize separately from the originally expressed surface receptors when they do not interact with substrate.
The P2/P1 ratio is increased upon activation, consistent with the larger platelets expressing more receptors on their surface compared to the smaller platelets. These results suggest that larger platelets are more activated than smaller platelets, as reported before. [25] [26] [27] [28] Upon thrombin activation, P-selectin and PAC-1 expressions in the larger platelets are increased much more than in the total and smaller platelets ( Figure 4A ). At higher thrombin concentrations, P-selectin and PAC-1 expressions in P2 became about 2-fold and 3-fold higher than that of P1 and P3, respectively. Since gating by flow cytometry cannot totally separate the larger platelets from the smaller platelets, these results suggest that activation involving integrin activation and secretion would mainly occur in the larger platelet population.
The large-platelet fraction isolated by differential centrifugation or flow cytometry was reported to be more active, [25] [26] [27] and a relationship between activity and platelet size was reported. 28 Although young platelets were thought to be large and more active, platelet size and age were indicated to independently affect platelet function. 29, 30 Heterogeneity of platelet size was suggested to come from the heterogeneity of megakaryocytes 31 and activation of the mechanistic target of rapamycin complex1 in megakaryocytes may contribute to elevated platelet volume, 9 suggesting that megakaryocytes would produce different sizes of platelets and that the larger platelet subpopulation would have higher activities. Our data indicate that the larger subpopulation of activated platelets showed a higher level of agonist-induced receptor expression compared to the total platelet population, supporting the previous reports describing that larger platelets have higher activities. In this context, it is very interesting that a larger MPV has been indicated to be a risk factor for cardiovascular disease in both men and women 7, 8, 32 or just in men. 33 Our results importantly suggest that the large-platelet subpopulation would be the main contributor to higher platelet activity and our method, analyzing the receptor expression of resting and activated platelets by flow cytometry, would be a good method to analyze the risk factor of having larger platelets.
